A paramagnetic chemical exchange-based MRI probe metabolized by cathepsin D: design, synthesis and cellular uptake

Mojmír Suchý1, Robert Ta, Alex X Li

  • 1Department of Chemistry, The University of Western Ontario, London, Ontario, Canada N6A 5B7.

Insights

A novel dual probe detects cathepsin D, an enzyme linked to cancer and Alzheimer's disease. This imaging tool shows promise for diagnosing diseases by visualizing enzyme activity.

Area of Science:

  • Biomedical Engineering
  • Molecular Imaging
  • Biochemistry

Background:

  • Cathepsin D overexpression is linked to cancer and Alzheimer's disease.
  • Cathepsin D is a potential imaging biomarker for disease detection.
  • Targeting specific enzyme activity is crucial for accurate disease diagnosis.

Purpose of the Study:

  • To synthesize a dual fluorescence/MRI probe for detecting localized cathepsin D activity.
  • To develop a novel imaging biomarker for diseases associated with cathepsin D.
  • To assess the probe's ability to selectively report cathepsin D activity in vitro.

Main Methods:

  • Synthesized a dual fluorescence/MRI probe incorporating MRI and optical reporters.
  • Linked reporters to a cell-penetrating peptide via a cathepsin D cleavable sequence.
  • Utilized fluorimetry for intracellular deposition assessment and OPARACHEE for MRI contrast detection.

Main Results:

  • The probe selectively deposited MRI and optical reporters intracellularly in the presence of overexpressed cathepsin D.
  • Fluorimetric analysis confirmed selective intracellular deposition.
  • The probe generated detectable in vitro MRI contrast via OPARACHEE.

Conclusions:

  • The synthesized dual probe effectively detects cathepsin D activity.
  • This probe demonstrates potential as an imaging biomarker for diseases like cancer and Alzheimer's.
  • The probe's design enables selective detection and provides dual-mode imaging capabilities.